Hang Seng Composite Index Series

EC Healthcare and Yoho Group Form Strategic Partnership

Retrieved on: 
Thursday, June 30, 2022
Efficiency, EYE, Hang Seng Composite Index Series, Raffles Medical Group, HAIR, Electronics, Precision medicine, EC, Party, Marketing, ECH, Growth, General officer, Awareness, Beauty, HEALTH, Partnership, SEHK, United States national laboratories, Health, NEW, Happiness, Group, Retail, Hospital

HONG KONG, June 30, 2022 - (ACN Newswire) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces that the Group signed a memorandum of understanding with Yoho Group Holdings Limited ("Yoho Group", SEHK stock code: 2347) for a strategic collaboration.

Key Points: 
  • HONG KONG, June 30, 2022 - (ACN Newswire) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces that the Group signed a memorandum of understanding with Yoho Group Holdings Limited ("Yoho Group", SEHK stock code: 2347) for a strategic collaboration.
  • The partnership will strengthen ECH's online presence in Hong Kong and expand its customer base and further consolidate the leading market position.
  • Under the collaboration, (i) The Group will become Yoho Group's anchor merchant in beauty and healthcare services and Yoho Group will launch an online medical, aesthetic medical and beauty and wellness service zone.
  • Mr. Gemini Wong, Executive Director, Chief Digital Officer and Deputy Marketing Officer of EC Healthcare said, "The Group is delighted to establish a strategic partnership with Yoho Group.

EC Healthcare Received "Institutional Investor" 2022 Multiple Awards in All-Asia Executive Team Rankings

Retrieved on: 
Monday, June 27, 2022
EYE, Hang Seng Composite Index Series, Raffles Medical Group, HAIR, Medication, Research, Precision medicine, EC, Intelligence, General officer, Health care, HEALTH, SEHK, United States national laboratories, Institutional Investor, Group, NEW, Professional, Healthcare, Management, Security (finance), Hospital

Recognized as an authoritative ranking by industries, "All-Asia Executive Team Rankings" celebrates the outstanding companies and management teams in Asia.

Key Points: 
  • Recognized as an authoritative ranking by industries, "All-Asia Executive Team Rankings" celebrates the outstanding companies and management teams in Asia.
  • Best Investor Relations Professional - Mr. Christopher Wong / Ms. Hermione He
    Best Investor Relations Professional - Mr. Christopher Wong
    Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, "The Group is honoured and grateful to receive these awards.
  • We will continue to spare tremendous effort with the aim of further consolidating the leading position in the healthcare market and maximizing our shareholder value.
  • The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.

EC Healthcare Announces FY2021/22 Annual Results

Retrieved on: 
Thursday, June 23, 2022
NEW, Tax, Social responsibility, Insurance, Pressure, Depreciation, HEALTH, Yoy, EYE, Group, Hang Seng Composite Index Series, General officer, Review, Intelligence, Technology, Compliance, EBITDA, Investment, Policy, Telehealth, SLL, SEHK, Industry, HK, COVID-19, Year, Raffles Medical Group, Frost, CMMB (Catholic Medical Mission Board), Professional, Operation Smile, United States national laboratories, Organization, Medical tourism, Laboratory, Environment, Company, Precision medicine, Growth, Acquisition, HAIR, Partnership, Beauty, Goal, EC, Tutoring, Property management, Medicine, Airline, Pharmaceutical industry, Risk management

HONG KONG, June 23, 2022 - (ACN Newswire) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces today its audited annual results for the fiscal year ended 31 March 2022 (the "Year").

Key Points: 
  • HONG KONG, June 23, 2022 - (ACN Newswire) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces today its audited annual results for the fiscal year ended 31 March 2022 (the "Year").
  • The Group's EBITDA (earnings before interest, taxes, depreciation, and amortization) increased by 35.0% YoY to a record high HK$536.4 million.
  • EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services.
  • The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism.

EC Healthcare Signs Inaugural Dual-Tranche Sustainability-Linked Facility, The First-of-its-Kind in Hong Kong Healthcare Industry

Retrieved on: 
Tuesday, June 21, 2022
General officer, NEW, Intelligence, Goal, Precision medicine, Raffles Medical Group, Professional, HEALTH, HAIR, Hang Seng Composite Index Series, HSBC, United Nations, SLL, EYE, Group, United States national laboratories, ESG, SEHK, EC, Property management, Hospital

The inaugural dual-tranche SLL Facility is a first-of-its-kind for a healthcare services provider in Hong Kong, complementing the Group's established status as a leading industry pioneer and reaffirms the importance of sustainability in the Group's future growth strategy.

Key Points: 
  • The inaugural dual-tranche SLL Facility is a first-of-its-kind for a healthcare services provider in Hong Kong, complementing the Group's established status as a leading industry pioneer and reaffirms the importance of sustainability in the Group's future growth strategy.
  • SGS Hong Kong Limited, a leading sustainability consultancy firm, acted as ESG consultant on the SLL Facility.
  • We are excited to set the stage for subsequent sustainable finance transactions in the Hong Kong healthcare market."
  • The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.

EC Healthcare Acquires Health Screening Services Chain, Further Expand Customer Base and Consolidate the Health Screening Market

Retrieved on: 
Monday, May 23, 2022
NEW, Hang Seng Composite Index Series, Audience, Leadership, Cardiology, HEALTH, Professional, SPINE, COVID-19, EC, SEHK, Obstetrics, UMH, Group, Precision medicine, Intelligence, Acquisition, Growth, KONG, HAIR, Health insurance, Hospital

The Target Group has a long-standing history in providing comprehensive health screening services in Hong Kong since 2002.

Key Points: 
  • The Target Group has a long-standing history in providing comprehensive health screening services in Hong Kong since 2002.
  • Upon completion of the acquisition, the Group shall operate a total of 6 health screening services centers, covering New Territories, Kowloon and Hong Kong Island, thereby further consolidating the health screening market in Hong Kong.
  • Leveraging on Target Group's wide loyal customers and its long-established reputation for premium services, the Group will effectively expand its customer base.
  • We believe that this acquisition will enable the Group to further consolidate the healthcare market and fortify our leadership in discretionary medical market.

NIO to be Added to The Hang Seng TECH Index as a Constituent Stock

Retrieved on: 
Monday, May 23, 2022
2600-series (CTA), ES6, Hang Seng Indexes Company, Company, U.S. Securities and Exchange Commission, Annual report, Battery, ES8, Hang Seng Index, Solution, NIO, Adaa Khan, SEHK, SUV, Forward-looking statement, Terminology, Technology, Hang Seng Composite Index Series, EC6, Motor vehicle, HKEX, Mobile backend as a service, Private Securities Litigation Reform Act, SEC, NYSE, GLOBE, Risk management

The Hang Seng TECH Index represents the 30 largest technology companies listed in Hong Kong that have high business exposure to technology themes and pass the index's screening criteria.

Key Points: 
  • The Hang Seng TECH Index represents the 30 largest technology companies listed in Hong Kong that have high business exposure to technology themes and pass the index's screening criteria.
  • In addition, the Company will also be included in the Hang Seng Composite Index as a constituent stock, effective June 13, 2022.
  • NIO Inc. is a pioneer and a leading company in the premium smart electric vehicle market.
  • NIO aims to build a community starting with smart electric vehicles to share joy and grow together with users.

Nissin Foods Achieves Steady 2022 Q1 Financial Results

Retrieved on: 
Friday, May 13, 2022
Company, Hang Seng Index, ECO Cup, FTSE SmallCap Index, COVID-19, Food science, Mainland, Efficiency, Miramar Hotel and Investment, Technology, Hang Seng Composite Index Series, Group, Yoy, Nissin Foods, Cup Noodles, Growth, Property management, Mainland China

HONG KONG, May 13, 2022 - (ACN Newswire) - Nissin Foods Company Limited ("Nissin Foods" or the "Company", and together with its subsidiaries, the "Group"; Stock code: 1475) today announced its unaudited first quarter financial information for the three months ended 31 March 2022 ("the Reporting Period").

Key Points: 
  • HONG KONG, May 13, 2022 - (ACN Newswire) - Nissin Foods Company Limited ("Nissin Foods" or the "Company", and together with its subsidiaries, the "Group"; Stock code: 1475) today announced its unaudited first quarter financial information for the three months ended 31 March 2022 ("the Reporting Period").
  • Gross profit margin was 31.3% (2021: 32.1%), mainly a result of the increased prices of raw materials and other production costs.
  • Revenue from Hong Kong operations increased by 6.6% YoY to HK$357.9 million due to a surge in demand of bag-type instant noodles.
  • Mr Kiyotaka ANDO, Executive Director, Chairman and Chief Executive Officer of Nissin Foods, said, "With the COVID-19 epidemic prevailing, people's livelihood and economic recovery have been surrounded with uncertainties.

EC Healthcare expects sales volume to increase 35% Y-o-Y to no less than HK$3 billion for the Year

Retrieved on: 
Thursday, April 21, 2022
Professional, Hang Seng Composite Index Series, Travel, Hong Kong Government Gazette, Year, Government, Obstetrics, COVID-19, HEALTH, UMH, KONG, Information technology, Group, Efficiency, SEHK, HAIR, SPINE, Hong Kong residents, NEW, Intelligence, Cardiology, Prevalence, Precision medicine, Pharmaceutical industry, Iron ore

Benefiting from the diversified business portfolio and continuous improvement in operation efficiency, the Group's business grew steadily against market headwinds.

Key Points: 
  • Benefiting from the diversified business portfolio and continuous improvement in operation efficiency, the Group's business grew steadily against market headwinds.
  • The Group also expanded business via organic growth and M&A so as to further consolidate its leading position.
  • The Group expects to record sales volume of no less than HK$3 billion for the Year, representing a no less than 35% Year-on-Year ("Y-o-Y") increase.
  • The overall sales performance of the Group for the second half of Year is expected to record a no less than 15% Y-o-Y increase.

EC Healthcare Acquires Veterinary Business, Further Consolidate the Pet Service Industry and Increase Market Shares

Retrieved on: 
Thursday, April 7, 2022
Acquisition, HAIR, Mission statement, Hang Seng Composite Index Series, NEW, Group, SEHK, Obstetrics, Cardiology, New Territories, HEALTH, Professional, Precision medicine, Intelligence, EC, SPINE, Income, UMH, KONG, Retail, Hospital

Upon completion of the Acquisition, the financial results of the Target Company will be consolidated into the consolidated financial statements of the Group.

Key Points: 
  • Upon completion of the Acquisition, the financial results of the Target Company will be consolidated into the consolidated financial statements of the Group.
  • The Target Company principally provides veterinary services in Tai Po with four registered veterinary surgeons.
  • We believe this acquisition will help the Group expand the veterinary business layout and service capability, and further increase the veterinary market share, thereby consolidating the Group's industry leadership as an integrated medical and healthcare group.
  • Looking ahead, the Group has been developing an enclosed healthcare ecosystem focused on satisfaction of customers and creating more value to further consolidate the healthcare market."

EC Healthcare Opens New Multi-Service Flagship Medical Centre at Central and Advanced Imaging Centre at Taikoo

Retrieved on: 
Monday, April 4, 2022
HAIR, Hang Seng Composite Index Series, NEW, Group, SEHK, Obstetrics, Chiropractic, Cardiology, New Territories, HEALTH, Professional, Precision medicine, Intelligence, Pain management, Ophthalmology, SPINE, UMH, KONG, Elective surgery, Hospital

The upper five floors of the New Flagship Centre offer services including but not limited to general medical, orthopedics, ophthalmology, chiropractic, physiotherapy and pain management and service centres have commenced operations.

Key Points: 
  • The upper five floors of the New Flagship Centre offer services including but not limited to general medical, orthopedics, ophthalmology, chiropractic, physiotherapy and pain management and service centres have commenced operations.
  • The other two floors will be an advanced imaging centre serving as a one-stop medical imaging service hub, which is expected to commence operation in the fourth quarter of 2022.
  • Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, "EC Healthcare has been developing preventive and precision medicine as its core businesses.
  • EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services.